Insider · CIK 0001664690

Deignan Charles A.

Reports to the SEC for 1 company · ALPHARETTA, GA

sec.gov

Transactions

Companies

Filings

CIK

0001664690

Forms 4 and 5

Insider transactions

38 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-01-08	CLSDQClearside Biomedical, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+200K sh	—	—	200,000
2024-01-19	CLSDQClearside Biomedical, Inc.S Sale	Chief Financial Officer	SSale	−12.9K sh	$1.28	−$16.5K	384,662
2024-01-18	CLSDQClearside Biomedical, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+200K sh	—	—	200,000
2023-09-18	CLSDQClearside Biomedical, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000
2023-09-13	CLSDQClearside Biomedical, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−34.1K sh	—	—	0
2023-09-13	CLSDQClearside Biomedical, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+34.1K sh	$0.40	+$13.6K	397,562
2023-01-19	CLSDQClearside Biomedical, Inc.S Sale	Chief Financial Officer	SSale	−14K sh	$1.50	−$21K	363,472
2023-01-04	CLSDQClearside Biomedical, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+188K sh	—	—	187,500
2022-12-20	CLSDQClearside Biomedical, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+23.6K sh	$0.40	+$9,454.4	377,502
2022-12-20	CLSDQClearside Biomedical, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−23.6K sh	—	—	0
2022-01-19	CLSDQClearside Biomedical, Inc.S Sale	Chief Financial Officer	SSale	−8,833 sh	$2.09	−$18.5K	351,366
2022-01-18	CLSDQClearside Biomedical, Inc.A Award	Chief Financial Officer	AAward	+43.8K sh	—	—	360,199
2022-01-18	CLSDQClearside Biomedical, Inc.A Award	Chief Financial Officer	AAward	+46.3K sh	—	—	362,699
2022-01-18	CLSDQClearside Biomedical, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+131K sh	—	—	131,250
2022-01-18	CLSDQClearside Biomedical, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+139K sh	—	—	138,750
2021-09-21	CLSDQClearside Biomedical, Inc.S Sale	Chief Financial Officer	SSale	−2,800 sh	$6.41	−$17.9K	316,449
2021-06-21	CLSDQClearside Biomedical, Inc.S Sale	Chief Financial Officer	SSale	−2,938 sh	$4.37	−$12.8K	319,249
2021-01-18	CLSDQClearside Biomedical, Inc.A Award	Chief Financial Officer	AAward	+96.4K sh	—	—	322,187
2021-01-18	CLSDQClearside Biomedical, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+196K sh	—	—	195,640
2020-06-01	CLSDQClearside Biomedical, Inc.S Sale	Chief Financial Officer	SSale	−15K sh	$1.88	−$28.2K	220,827
2020-01-08	CLSDQClearside Biomedical, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+75K sh	—	—	75,000
2020-01-08	CLSDQClearside Biomedical, Inc.A Award	Chief Financial Officer	AAward	+25K sh	—	—	228,856
2019-11-12	CLSDQClearside Biomedical, Inc.P Purchase	Chief Financial Officer	PPurchase	+7,500 sh	$1.14	+$8,550	203,856
2019-09-18	CLSDQClearside Biomedical, Inc.A Award	Chief Financial Officer	AAward	+70K sh	—	—	196,356
2019-05-31	CLSDQClearside Biomedical, Inc.A Award	Chief Financial Officer	AAward	+50K sh	—	—	126,356
2019-03-15	CLSDQClearside Biomedical, Inc.P Purchase	Chief Financial Officer	PPurchase	+10K sh	$1.36	+$13.6K	76,356
2019-02-05	CLSDQClearside Biomedical, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000
2018-03-23	CLSDQClearside Biomedical, Inc.P Purchase	Chief Financial Officer	PPurchase	+500 sh	$11.79	+$5,895	66,356
2017-12-08	CLSDQClearside Biomedical, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+96K sh	—	—	96,000
2017-08-14	CLSDQClearside Biomedical, Inc.P Purchase	Chief Financial Officer	PPurchase	+1,000 sh	$7.07	+$7,065	65,309
2017-06-30	CLSDQClearside Biomedical, Inc.A Award	Chief Financial Officer	AAward	+1,550 sh	$7.74	+$12K	64,309
2016-12-15	CLSDQClearside Biomedical, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+96K sh	—	—	96,000
2016-07-21	CLSDQClearside Biomedical, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+30K sh	—	—	30,000
2016-06-07	CLSDQClearside Biomedical, Inc. · Warrant to Purchase Common Stock (right to buy)X Exercise of In-Money	Chief Financial Officer	XExercise of In-Money	−470 sh	—	—	0
2016-06-07	CLSDQClearside Biomedical, Inc.S Sale	Chief Financial Officer	SSale	−2 sh	$7.00	−$14	62,759
2016-06-07	CLSDQClearside Biomedical, Inc.C Conversion	Chief Financial Officer	CConversion	+4,261 sh	—	—	62,291
2016-06-07	CLSDQClearside Biomedical, Inc.X Exercise of In-Money	Chief Financial Officer	XExercise of In-Money	+470 sh	$0.02	+$10.34	62,761
2016-06-07	CLSDQClearside Biomedical, Inc. · Series B Preferred StockC Conversion	Chief Financial Officer	CConversion	−9,375 sh	—	—	0

Recent filings

Accepted (ET)
Jan 104
Deignan Charles A.0001415889-25-001282
SEC(opens sec.gov)
Jan 194
Deignan Charles A.0001209191-24-001959
SEC(opens sec.gov)
Sep 204
Deignan Charles A.0001209191-23-050162
SEC(opens sec.gov)
Sep 134
Deignan Charles A.0001209191-23-049346
SEC(opens sec.gov)
Jan 204
Deignan Charles A.0001209191-23-004258
SEC(opens sec.gov)
Jan 64
Deignan Charles A.0001209191-23-002344
SEC(opens sec.gov)
Dec 204
Deignan Charles A.0001209191-22-062169
SEC(opens sec.gov)
Jan 284/A
Deignan Charles A.0001209191-22-005437
SEC(opens sec.gov)
Jan 204
Deignan Charles A.0001209191-22-004194
SEC(opens sec.gov)
Sep 234
Deignan Charles A.0001209191-21-057457
SEC(opens sec.gov)
Jun 234
Deignan Charles A.0001209191-21-042803
SEC(opens sec.gov)
Jan 204
Deignan Charles A.0001209191-21-004476
SEC(opens sec.gov)
Jun 34
Deignan Charles A.0001209191-20-034062
SEC(opens sec.gov)

Companies

Clearside Biomedical, Inc.Chief Financial OfficerCLSDQ

Address

C/O CLEARSIDE BIOMEDICAL, INC. 900 NORTH POINT PARKWAY, SUITE 200

ALPHARETTA, GA, 30005